Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis

Clinical Cancer Research

Volumn 11, Issue 10, 2005, Pages 3647-3653

  Jin, Qianren ^a   Hemminki, Kari ^a,b   Enquist, Kerstin ^c   Lenner, Per ^d   Grzybowska, Ewa ^e   Klaes, Rüdiger ^b   Henriksson, Roger ^d   Chen, Bowang ^b   Pamula, Jolanta ^e   Pekala, Wioletta ^e   Zientek, Helena ^e   Rogozinska Szczepka, Jadwiga ^e   Utracka Hutka, Beata ^e   Hallmans, Göran ^c   Försti, Asta ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UMEÅ UNIVERSITY   (Sweden)

^d UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^e INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; FAMILIAL CANCER; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; SWEDEN; TUMOR GROWTH;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PEDIGREE; POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 21044453002     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-1803     Document Type: Article

References (23)

1. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9:669-76.
2. Morabito A, Sarmiento R, Bonginelli P, Gasparini G. Antiangiogenic strategies, compounds, and early clinical results in breast cancer. Crit Rev Oncol Hematol 2004;49:91-107.
3. Nakamura M, Abe Y, Tokunaga T. Pathological significance of vascular endothelial growth factor A isoform expression in human cancer. Pathol Int 2002;52:331-9.
4. Yang B, Cross DF, Ollerenshaw M, Millward BA, Demaine AG. Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus. J Diabetes Complications 2003;17:1-6.
5. Mohammadi M, Ollier WE, Hutchinson IV. A functional association study of VEGF gene promoter polymorphisms with VEGF expression by stimulated pbm cells. Hum Immunol 2003;64:S125.
6. Shahbazi M, Fryer AA, Pravica V, et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 2002;13:260-4.
7. Awata T, Inoue K, Kurihara S, et al. A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002;51:1635-9.
8. Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 2000;37:443-8.
9. Krippl P, Langsenlehner U, Renner W, et al. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 2003;106:468-71.
10. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000;12:1232-5.
11. Howell WM, Bateman AC, Turner SJ, Collins A, Theaker JM. Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma. Genes Immun 2002;3:229-32.
12. McCarron SL, Edwards S, Evans PR, et al. Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res 2002;62:3369-72.
13. Linderholm B, Grankvist K, Wilking N, Johansson M, Tavelin B, Henriksson R. Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment. J Clin Oncol 2000;18:1423-31.
14. Jin Q, Hemminki K, Grzybowska E, et al. Polymorphisms and haplotype structures in genes for0 transforming growth factor b1 and its receptors in familial and unselected breast cancers. Int J Cancer 2004;112:94-9.
15. Kaaks R, Lundin E, Rinaldi S, et al. Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden. Cancer Causes Control 2002;13:307-16.
16. Forsti A, Jin Q, Grzybowska E, et al. Sex hormone-binding globulin polymorphisms in familial and sporadic breast cancer. Carcinogenesis 2002;23:1315-20.
17. Forsti A, Jin Q, Sundqvist L, Soderberg M, Hemminki K. Use of monozygotic twins in search for breast cancer susceptibility loci. Twin Res 2001;4:251-9.
18. Brogan IJ, Khan N, Isaac K, Hutchinson JA, Pravica V, Hutchinson IV. Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 1999;60:1245-9.
19. Lambrechts D, Storkebaum E, Morimoto M, et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 2003;34:383-94.
20. Stevens A, Soden J, Brenchley PE, Ralph S, Ray DW. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 2003;63:812-6.
21. Balasubramanian SP, Brown NJ, Reed MW. Role of genetic polymorphisms in tumour angiogenesis. Br J Cancer 2002;87:1057-65.
22. Houlston RS, Peto J. The future of association studies of common cancers. Hum Genet 2003;112:434-5.
23. Antoniou AC, Easton DF. Polygenic inheritance of breast cancer: Implications for design of association studies. Genet Epidemiol 2003;25:190-202.